GSK: Sir Andrew Witty's pay halves amid weak European performance Of the total pay packet, £1.03m was his base salary, up 3pc from the previous year. A further £49,000 was paid out as "other benefits," such as healthcare, a company car or personal financial advice. Of his total pay, Sir Andrew's annual bonus was £905,000, down from £2m in 2011. He also earned a further £125,000 as part of a deferred bonus plan. His performance share plan fell by more than half to £1.78m. The company blames severe "price pressures" in Europe, where governments have cut medicine prices by as much as 7pc and which coupled with a lower demand for vaccines, have hit sales. Last year, GSK announced a review of its European operations, which is likely to see the drug maker move resources away from continental Europe into buoyant emerging markets. Elsewhere, the annual report set out what Sir Andrew could earn this year, under different scenarios. In the best case, if all performance targets are met, the chief executive could earn £10.7m, which includes a bonus worth twice his salary and a performance share plan worth six times his 2013 salary of £1.06m. In reality however, it is expected he is more likely to earn a figure closer to the average scenario of £3.5m. GSK declined to comment.